VDAC1 and COVID-19: In addition, COVID-19 patients’ T-cells underwent apoptosis that was inhibited by VBIT-4 (Thompson et al., 2020), a compound that targets VDAC1 oligomerization and prevents apoptosis (Ben-Hail et al., 2016).